Compare CADL & ORN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CADL | ORN |
|---|---|---|
| Founded | 1999 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 578.8M | 555.4M |
| IPO Year | 2021 | 2007 |
| Metric | CADL | ORN |
|---|---|---|
| Price | $8.83 | $13.93 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 4 |
| Target Price | ★ $19.00 | $16.25 |
| AVG Volume (30 Days) | ★ 2.2M | 396.0K |
| Earning Date | 05-14-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 58.62 | ★ 220.00 |
| EPS | N/A | ★ 0.12 |
| Revenue | $125,000.00 | ★ $852,260,000.00 |
| Revenue This Year | N/A | $8.50 |
| Revenue Next Year | N/A | $7.83 |
| P/E Ratio | ★ N/A | $117.50 |
| Revenue Growth | N/A | ★ 7.01 |
| 52 Week Low | $4.35 | $6.44 |
| 52 Week High | $9.27 | $15.85 |
| Indicator | CADL | ORN |
|---|---|---|
| Relative Strength Index (RSI) | 68.29 | 49.31 |
| Support Level | $4.80 | $13.20 |
| Resistance Level | $9.27 | $14.20 |
| Average True Range (ATR) | 0.60 | 0.67 |
| MACD | -0.04 | -0.19 |
| Stochastic Oscillator | 75.28 | 27.37 |
Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
Orion Group Holdings Inc is a specialty construction company serving the infrastructure, industrial, and building sectors, providing services both on and off the water in the continental United States, Alaska, Canada, and the Caribbean Basin through its marine segment and its concrete segment. Its marine segment provides construction and dredging services relating to marine transportation facility construction, marine pipeline construction, marine environmental structures, dredging of waterways, channels and ports, environmental dredging, design, and specialty services. The concrete segment generates maximum revenue and provides construction services for commercial, industrial, multi-family residential, and public projects, including the data center market.